Course of indolent Crohn's disease in a prospective European population-based inception cohort with five years follow-up - the Epi-IBD cohort

(1) Hvidovre University Hospital,Virum,Denmark

(2) University of Medicine ‘Victor Babes’,Timisoara,Romania

(3) Herning Central Hospital,Herning,Denmark

(4) Soroke MC,Beer Sheva,Israel

(5) National Hospital of the Faroe Islands,Torshavn,Faroe Islands

(6) Imperial College London,London,United Kingdom

(7) Amiens University Hospital,Amiens,France

(8) Lithuanian University of Health Sciences Inst. for Digestive Research,Kaunas,Lithuania

(9) Aarhus University Hospital,Aarhus,Denmark

(10) Moscow Regional Research Clinical Institute named after MF Vladimirsky,Moscow,Russian Federation

(11) Tampere University Hospital,Tampere,Finland

(12) Hospital Álvaro Cunqueiro. Instituto Investigación Sanitaria Galicia Sur,Redondela,Spain

(13) Herlev Hospital,Herlev,Denmark

(14) The State University of Medicine and Pharmacy 'N.Testemitanu',Chisinau,Moldova (Republic of)

(15) Morgagni Hospital,Forli,Italy

(16) Ospedale Careggi,Florence,Italy

(17) Centro Hospitalar São João,Amadora,Portugal

(18) ISCARE I.V.F. a.s.,Prague,Czech Republic

(19) Tartu University Hospital,Tartu,Estonia

(20) American Gastroenterology Center,Nicosia,Cyprus

(21) McGill University Health Center,Montreal,Canada

(22) Medical School of Ioannina,Ioannina,Greece

(23) Mater Dei Hospital,Msida,Malta

(24) KBC Zagreb,Zagreb,Croatia

(25) Division of Gastroenterology,Padova,Italy

(26) Slagelse Hospital,Slagelse,Denmark

(27) ShS Aabenraa,Viborg,Denmark

(28) Örebro University,Örebro,Sweden

(29) Hull Royal Infirmary,Hull,United Kingdom



This item was part of the Epidemiology and treatment of IBD session at UEG Week 2019

This item can be cited as: United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019